(Total Views: 573)
Posted On: 10/07/2021 9:13:18 AM
Post# of 148898
Proactive Live alert CytoDyn Inc. - CytoDyn announces study to evaluate potential synergistic effects of Leronlimab with immune checkpoint blockade
I believe this gives more detail than the CytoDyn PR this morning.
https://www.proactiveinvestors.com/companies/...62561.html
I believe this gives more detail than the CytoDyn PR this morning.
https://www.proactiveinvestors.com/companies/...62561.html
(1)
(0)
My comments are just my opinions and should NOT be taken as investment advice.
Scroll down for more posts ▼
